Trial Profile
MNK-155 Human Abuse Liability (HAL) Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Sep 2014
Price :
$35
*
At a glance
- Drugs Hydrocodone/paracetamol (Primary)
- Indications Pain
- Focus Pharmacodynamics
- Sponsors Mallinckrodt Inc.
- 11 Sep 2014 New trial record
- 03 Sep 2014 Primary endpoint has been met. (Abuse liability)
- 03 Sep 2014 Results published in the Media Release and presented at PAINWeek 2014.